Hanson McClain Advisors »

Relmada Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.7k 2.0k 4.83
2023-09-30 $267 89 3.00
2023-06-30 $388 158 2.46
2023-03-31 $357 158 2.27
2022-12-31 $311 89 3.49

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Hanson McClain Advisors

Top funds holding Relmada Therapeutics

Marshall Wace
Ikarian Capital
Braidwell
BlackRock
Vanguard Group
Opaleye Management
Geode Capital Management
Boothbay Fund Management
Driehaus Capital Management
CI Private Wealth
Acadian Asset Management
Susquehanna International
Diadema Partners
State Street Corporation
AdvisorShares Investments

View all funds holding Relmada Therapeutics